.Bristol Myers Squibb is actually axing an additional significant bet coming from the Caforio time, ...
.After having a look at period 1 information, Nuvation Bio has made a decision to halt focus on its ...
.Zevra Therapeutics' uncommon illness medicine appears to become on the course to approval this autu...
.Pfizer's period 3 Duchenne muscular dystrophy (DMD) genetics treatment failing has blown a $230 tho...
.After more than 20 years of deal with neurodegenerative illness, Swiss biotech a/c Immune system in...
.GSK has actually broken up a stage 2 human papillomavirus (HPV) injection coming from its own pipel...
.Operating system Therapies will certainly list on the NYSE American stock exchange today using a $6...
.ALX Oncology's phase 2 stomach cancer cells reaction cost has compromised. After seeing its CD47 bl...
.Yet Another of Ionis Pharmaceuticals' vital midphase readouts has actually fallen short of expectat...
.While Biogen's pharma peers are hunting for late-stage assets along with little risk, chief executi...